Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 10843166)

1.

Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J.

J Clin Endocrinol Metab. 2000 May;85(5):1863-7.

PMID:
10843166
2.

Familial hyperaldosteronism.

Torpy DJ, Stratakis CA, Chrousos GP.

Braz J Med Biol Res. 2000 Oct;33(10):1149-55. Review.

3.

Primary aldosteronism: learning from the study of familial varieties.

Stowasser M, Gordon RD.

J Hypertens. 2000 Sep;18(9):1165-76. Review.

PMID:
10994747
4.

New genetic insights in familial hyperaldosteronism.

Jackson RV, Lafferty A, Torpy DJ, Stratakis C.

Ann N Y Acad Sci. 2002 Sep;970:77-88. Review.

PMID:
12381543
5.

Familial hyperaldosteronism.

Stowasser M, Gordon RD.

J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29. Review.

PMID:
11595502
6.

[Low-renin hypertension and inherited mineralocorticoid diseases].

Kastelan D, Giljević Z, Perković Z, Plavsić V, Breskovac L, Aganović I, Korsić M.

Lijec Vjesn. 1999 Jul-Aug;121(7-8):245-9. Review. Croatian.

PMID:
10573960
7.

Glucocorticoid-remediable aldosteronism.

McMahon GT, Dluhy RG.

Cardiol Rev. 2004 Jan-Feb;12(1):44-8. Review.

PMID:
14667264
8.

[Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].

Omura M, Nishikawa T.

Rinsho Byori. 2006 Nov;54(11):1157-63. Review. Japanese.

PMID:
17240838
9.

Genetic alterations in patients with primary aldosteronism.

Takeda Y.

Hypertens Res. 2001 Sep;24(5):469-74. Review.

10.

Detecting and treating primary aldosteronism: primary aldosteronism.

Mantero F, Mattarello MJ, Albiger NM.

Exp Clin Endocrinol Diabetes. 2007 Mar;115(3):171-4. Review.

PMID:
17427105
11.

Glucocorticoid-remediable aldosteronism.

Williams GH, Dluhy RG.

J Endocrinol Invest. 1995 Jul-Aug;18(7):512-7. Review.

PMID:
9221269
12.

Disorders of steroid 11 beta-hydroxylase isozymes.

White PC, Curnow KM, Pascoe L.

Endocr Rev. 1994 Aug;15(4):421-38. Review.

PMID:
7988480
13.

Screening and diagnosis of primary aldosteronism.

Rayner BL.

Cardiovasc J S Afr. 2002 Jul-Aug;13(4):166-70. Review.

14.

Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.

Piaditis G, Markou A, Papanastasiou L, Androulakis II, Kaltsas G.

Eur J Endocrinol. 2015 May;172(5):R191-203. doi: 10.1530/EJE-14-0537. Epub 2014 Dec 23. Review.

15.

The renaissance of primary aldosteronism: what has it taught us?

Stowasser M, Gordon RD.

Heart Lung Circ. 2013 Jun;22(6):412-20. doi: 10.1016/j.hlc.2013.01.006. Epub 2013 Feb 9. Review.

PMID:
23402683
16.

Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension.

Moraitis AG, Rainey WE, Auchus RJ.

Appl Clin Genet. 2013 Dec 24;7:1-13. doi: 10.2147/TACG.S35571. Review.

17.

The molecular basis of primary aldosteronism: from chimeric gene to channelopathy.

Lenzini L, Rossi GP.

Curr Opin Pharmacol. 2015 Apr;21:35-42. doi: 10.1016/j.coph.2014.12.005. Epub 2014 Dec 30. Review.

PMID:
25555247
18.

Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis.

Chen W, Li F, He C, Zhu Y, Tan W.

Ir J Med Sci. 2014 Jun;183(2):283-91. doi: 10.1007/s11845-013-1007-x. Epub 2013 Aug 30. Review.

PMID:
23990176
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk